Enhanced COPD Management in Suspected Lung Cancer Patients
Recruiting
N/A
Interventional Study
COPD (Chronic Obstructive Pulmonary Disease)
Lung Cancer (Diagnosis)
Lung Neoplasm Malignant
Lung Carcinoma
Pulmonary Neoplasms
Pulmonary Neoplasm
Pulmonary Cancers
Pulmonary Cancer
Pulmonary Carcinoma
COPD
COPD - Chronic Obstructive Pulmonary Disease
Airflow Obstruction, Chronic
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 280 (estimated)
- Sponsor
- Ditte Krag-Hansen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates.
This study aims to assess the impact of early diagnosis and optimal treatment of COPD on clinical outcomes in patients under evaluation for lung ca…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Undergoing diagnostic evaluation for suspected lung cancer
* Spirometry showing obstructive airflow limitation (FEV₁/FVC \< 75 % or FEV₁ \< 80 %, and no reversibility) at the first outpatient visit at the lung cancer evaluation
Exclusion Criteria:
* Presence of significant c…
Contacts